News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
485,846 Results
Type
Article (8016)
Company Profile (140)
Press Release (477689)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166740)
Career Advice (304)
Deals (25738)
Drug Delivery (7)
Drug Development (52873)
Employer Resources (14)
FDA (9760)
Job Trends (8572)
News (238193)
Policy (17898)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (489)
Accelerated approval (26)
ADA (18)
Adcomms (1)
Allergies (98)
Alliances (33154)
ALS (108)
Alzheimer's disease (984)
Antibody-drug conjugate (ADC) (280)
Approvals (10401)
Artificial intelligence (329)
ASCO (159)
Autoimmune disease (218)
Automation (29)
Bankruptcy (263)
Belgium (1)
Best Places to Work (6958)
BIO (36)
Biologics (9)
BIOSECURE Act (1)
Biosimilars (114)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (139)
Brain cancer (31)
Breast cancer (518)
Cancer (3747)
Cardiovascular disease (226)
Career advice (245)
Career pathing (1)
CAR-T (177)
CDMO (13)
Celiac Disease (1)
Cell therapy (485)
Cervical cancer (35)
Clinical research (48019)
Collaboration (1273)
Commercialization (3)
Compensation (1524)
Complete response letters (34)
COVID-19 (759)
CRISPR (64)
C-suite (800)
Cystic fibrosis (87)
Data (5834)
Denatured (4)
Depression (106)
Dermatology (67)
Diabetes (351)
Diagnostics (4207)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (158)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (166)
Earnings (73748)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88077)
Executive appointments (712)
FDA (12468)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (24)
Funding (940)
Gene editing (126)
Generative AI (9)
Gene therapy (331)
GLP-1 (294)
Government (946)
Grass and pollen (2)
Guidances (281)
Healthcare (9367)
Hematology (94)
HIV (53)
Huntington's disease (22)
IgA nephropathy (68)
Immunology and inflammation (101)
Immuno-oncology (61)
Indications (161)
Infectious disease (950)
Inflammatory bowel disease (128)
Inflation Reduction Act (4)
Influenza (85)
Intellectual property (259)
Interviews (41)
IPO (12387)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5195)
Licensing (17)
Liver cancer (45)
Longevity (19)
Lung cancer (535)
Lymphoma (257)
Machine learning (27)
Management (3)
Manufacturing (560)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8676)
Medtech (8832)
Mergers & acquisitions (14406)
Metabolic disorders (722)
mRNA (60)
Multiple sclerosis (107)
NASH (4)
Neurodegenerative disease (226)
Neuropsychiatric disorders (40)
Neuroscience (1863)
NextGen: Class of 2026 (3150)
Non-profit (843)
Obesity (230)
Opinion (10)
Ovarian cancer (161)
Pain (177)
Pancreatic cancer (206)
Parkinson's disease (205)
Partnered (12)
Patents (494)
Patient recruitment (528)
Patient selection (1)
Peanut (32)
People (41341)
Peptides (1)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15511)
Phase 2 (21443)
Phase 3 (14457)
Pipeline (7650)
Policy (18)
Postmarket research (1570)
Preclinical (6551)
Press Release (34)
Prostate cancer (193)
Psychedelics (7)
Radiopharmaceuticals (194)
Rare diseases (586)
Real estate (3022)
Recruiting (6)
Regenerative medicine (1)
Regulatory (14928)
Reports (23)
Research institute (584)
Resumes & cover letters (45)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (102)
Series A (160)
Series B (122)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (90)
Sponsored (5)
Startups (2020)
Stomach cancer (3)
Supply chain (51)
Vaccines (332)
Venture capital (17)
Weight loss (74)
Women's health (86)
Date
Today (82)
Last 7 days (391)
Last 30 days (1407)
Last 365 days (19123)
2026 (13482)
2025 (19251)
2024 (22986)
2023 (26538)
2022 (34586)
2021 (37167)
2020 (33468)
2019 (23275)
2018 (17468)
2017 (18765)
2016 (17917)
2015 (24263)
2014 (21684)
2013 (18135)
2012 (20221)
2011 (20441)
2010 (20333)
Location
Africa (229)
Alabama (77)
Alaska (2)
Arizona (309)
Arkansas (11)
Asia (17954)
Australia (2106)
California (12305)
Canada (3225)
China (542)
Colorado (494)
Connecticut (427)
Delaware (211)
Europe (24695)
Florida (1847)
Georgia (393)
Hawaii (3)
Idaho (46)
Illinois (726)
India (52)
Indiana (321)
Iowa (16)
Japan (419)
Kansas (102)
Kentucky (31)
Louisiana (27)
Maine (26)
Maryland (1227)
Massachusetts (8080)
Michigan (312)
Minnesota (572)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (122)
New Hampshire (60)
New Jersey (2683)
New Mexico (12)
New York (2887)
North Carolina (1313)
North Dakota (4)
Northern California (6185)
Ohio (292)
Oklahoma (14)
Oregon (18)
Pennsylvania (2292)
Puerto Rico (21)
Rhode Island (30)
South America (406)
South Carolina (77)
South Dakota (1)
Southern California (5120)
Tennessee (123)
Texas (1996)
United States (39901)
Utah (368)
Vermont (1)
Virginia (159)
Washington D.C. (38)
Washington State (955)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
485,846 Results for "infusystem inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
InfuSystem Announces Financial Results for Second Quarter 2026
August 4, 2026
·
19 min read
Press Releases
InfuSystem Announces Financial Results for Fourth Quarter and Full Year 2025
February 24, 2026
·
19 min read
Press Releases
InfuSystem to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
February 17, 2026
·
1 min read
Press Releases
InfuSystem to Report Second Quarter 2025 Financial Results on August 5, 2025
July 29, 2025
·
1 min read
BioMidwest
InfuSystem to Present at Sidoti Small Cap Conference on June 12, 2024
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”) announced today that Richard DiIorio, Chief Executive Officer, Barry Steele, Chief Financial Officer, and Carrie Lachance, President and Chief Operating Officer, will present at the Sidoti Small Cap Virtual Investor Conference at 8:30 a.m. ET on Wednesday, June 12, 2024.
June 4, 2024
·
4 min read
Business
InfuSystem to Report First Quarter 2024 Financial Results on May 9, 2024
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue first quarter 2024 financial results on Thursday, May 9, 2024, before the market opens.
May 2, 2024
·
1 min read
Business
InfuSystem to Report Fourth Quarter and Full Year 2023 Financial Results on March 14, 2024
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”) announced today it will issue preliminary fourth quarter and full year 2023 financial results on Thursday, March 14, 2024, before the market opens.
March 8, 2024
·
2 min read
Business
InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2023
InfuSystem Holdings, Inc. reported financial results for the fourth quarter and full year ended December 31, 2023.
March 14, 2024
·
23 min read
Press Releases
InfuSystem to Report First Quarter 2025 Financial Results on May 8, 2025
May 1, 2025
·
1 min read
BioMidwest
InfuSystem to Present at Sidoti Small-Cap Virtual Conference on December 6, 2023
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”) will present at the Sidoti Small-Cap Virtual Investor Conference at 8:30 a.m. ET on Wednesday, December 6, 2023.
November 28, 2023
·
4 min read
1 of 48,585
Next
